Description

6-[4-(1,3-Benzodioxol-5-Ylmethyl)-1-Piperazinyl]-9-(2-Methoxyphenyl)-9H-Purine is a high-purity, complex heterocyclic compound of significant interest in advanced pharmaceutical research and development. This molecule serves as a critical intermediate or active pharmaceutical ingredient (API) for the synthesis of novel therapeutic agents targeting neurological and psychiatric disorders. It is primarily utilized by research institutions, pharmaceutical R&D departments, and fine chemical manufacturers engaged in the development of central nervous system (CNS) drugs and other specialized medicinal chemistry applications.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel purine-based drug candidates for CNS applications.
• Neurological Research: Used in preclinical studies to investigate potential treatments for conditions like anxiety, depression, and cognitive disorders.
• Medicinal Chemistry: Serves as a core scaffold for structure-activity relationship (SAR) studies to optimize pharmacological profiles.
• Reference Standard: Employed as an analytical standard in quality control laboratories for method development and validation.
• Biochemical Research: Utilized in studies exploring enzyme inhibition and receptor binding activities relevant to drug discovery.
• Fine Chemical Synthesis: Intermediate for the production of more complex, target-specific molecules in custom synthesis projects.

Basic Information

Product Name	6-[4-(1,3-Benzodioxol-5-Ylmethyl)-1-Piperazinyl]-9-(2-Methoxyphenyl)-9H-Purine
CAS No.	37425-32-4
Molecular Formula	C24H24N6O3
Molecular Weight	444.49 g/mol
Synonyms	9-(2-Methoxyphenyl)-6-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-9H-purine; 6-[4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl]-9-(2-methoxyphenyl)-9H-purine; 37425-32-4; 9H-Purine, 6-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-9-(2-methoxyphenyl)-; STK295900; BDBM50111657; AKOS015903065; ZINC000003869777
EINECS	Contact for details

Quality Control

Our 6-[4-(1,3-Benzodioxol-5-Ylmethyl)-1-Piperazinyl]-9-(2-Methoxyphenyl)-9H-Purine is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatograms and spectral data are provided for full traceability and regulatory support.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.